SETDB1 and hepatocellular carcinoma: Furthermore, SH tumors are specifically enriched in ferroptosis‐resistant gene programs, suggesting that SETDB1 may suppress ferroptosis-related pathways, a key mechanism of therapeutic failure in HCC.